BONTAC BIO-ENGINEERING SHENZHEN CO LTD

Overview

BONTAC BIO-ENGINEERING SHENZHEN CO LTD is an active pharmaceutical ingredient (API) supplier with 10 active FDA Type II Drug Master Files, covering NATURAL KILLER CELLS INDUCTION CULTURE KIT 2.0; ß-NICOTINAMIDE ADENINE DINUCLEOTIDE; SUPERCULTURE GF 20 MSC XENO-FREE SFM; SUPERCULTURE HUMAN MESENCHYMAL STEM CELLS CULTURE KIT; SUPERCULTURE™ GF20 PLUS MSC XENO-FREE SFM; SUPERCULTURE™ L100 SERUM FREE MEDIUM FOR LYMPHOCYTE.

API / Drug Master Files

BONTAC BIO-ENGINEERING SHENZHEN CO LTD holds 10 active (10 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• SUPERCULTURE™ GF20 PLUS MSC XENO-FREE SFMActive2024-01-04
• SUPERCULTURE™ PSE8 HUMAN PLURIPOTENT STEM CELL MEDIUMActive2024-01-04
• TRYPSIN DIGESTIVE REAGENTActive2023-05-16
• SUPERCULTURE™ MESENCHYMAL STEM CELL BASAL MEDIUMActive2023-03-31
• SUPERCULTURE™ L100 SERUM FREE MEDIUM FOR LYMPHOCYTEActive2022-08-06
• NATURAL KILLER CELLS INDUCTION CULTURE KIT 2.0Active2022-07-17
• SUPERCULTURE™ N500 SERUM FREE MEDIUM FOR NK CELLSActive2022-01-04
• SUPERCULTURE GF 20 MSC XENO-FREE SFMActive2021-10-21
• SUPERCULTURE HUMAN MESENCHYMAL STEM CELLS CULTURE KITActive2021-06-30
• ß-NICOTINAMIDE ADENINE DINUCLEOTIDEActive2021-05-24

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to BONTAC BIO-ENGINEERING SHENZHEN CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.